PHATHOM PHARMACEUTICALS, INC.

Transcripts Phathom Pharmaceuticals, Inc.

Equities

PHAT

US71722W1071

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
9.42 ^USD	-7.56%		-10.29%	+3.18%

May. 09	Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Transcript : Phathom Pharmaceuticals, Inc. - Special Call	Nov. 02
Transcript : Phathom Pharmaceuticals, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 08:00 AM	23-06-14
Transcript : Phathom Pharmaceuticals, Inc. - Special Call	21-10-18
Transcript : Phathom Pharmaceuticals, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-14-2021 11:00 AM	21-09-14
Transcript : Phathom Pharmaceuticals, Inc. - Shareholder/Analyst Call	21-05-21
Transcript : Phathom Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-13-2021 08:45 AM	21-05-13
Transcript : Phathom Pharmaceuticals, Inc. - Special Call	21-04-29
Transcript : Phathom Pharmaceuticals, Inc. - Analyst/Investor Day	20-12-14
Transcript : Phathom Pharmaceuticals, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-15-2020 03:30 PM	20-09-15
Transcript : Phathom Pharmaceuticals, Inc. Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-11-2020 11:10 AM	20-06-11
Transcript : Phathom Pharmaceuticals, Inc. - Shareholder/Analyst Call	20-05-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer